MRNAI GOLD Trademark

Trademark Overview


On Tuesday, January 12, 2021, a trademark application was filed for MRNAI GOLD with the United States Patent and Trademark Office. The USPTO has given the MRNAI GOLD trademark a serial number of 90460577. The federal status of this trademark filing is REGISTERED as of Tuesday, May 23, 2023. This trademark is owned by Silence Therapeutics GmbH. The MRNAI GOLD trademark is filed in the Chemical Products category with the following description:

An oligonucleotide discovery platform, namely, chemically modified siRNA for making chemical preparations and substances for scientific and research use
mrnai gold

General Information


Serial Number90460577
Word MarkMRNAI GOLD
Filing DateTuesday, January 12, 2021
Status700 - REGISTERED
Status DateTuesday, May 23, 2023
Registration Number7062669
Registration DateTuesday, May 23, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesAn oligonucleotide discovery platform, namely, chemically modified siRNA for making chemical preparations and substances for scientific and research use
Disclaimer with Predetermined Text"MRNAI"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, April 12, 2021
Primary Code001
First Use Anywhere DateTuesday, November 8, 2022
First Use In Commerce DateTuesday, November 8, 2022

Trademark Owner History


Party NameSilence Therapeutics GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBerlin 13125
DE

Party NameSilence Therapeutics GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBerlin 13125
DE

Party NameSilence Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerlin 13125
DE

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 23, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 20, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 19, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 27, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 4, 2023USE AMENDMENT FILED
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 4, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 4, 2022SOU EXTENSION 1 GRANTED
Sunday, December 4, 2022SOU EXTENSION 1 FILED
Sunday, December 4, 2022TEAS EXTENSION RECEIVED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 12, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, February 10, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 10, 2022FINAL REFUSAL E-MAILED
Thursday, February 10, 2022FINAL REFUSAL WRITTEN
Friday, January 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2021NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2021NON-FINAL ACTION WRITTEN
Thursday, July 22, 2021ASSIGNED TO EXAMINER
Monday, April 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 15, 2021NEW APPLICATION ENTERED